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Abstract: Low-back pain has a high impact on the world population, and solutions are in demand.
The behavior of specific physiological processes has been modified using magnetic fields, whether for
pain relief, bone consolidation, or improvement of vascularization. The use of tape with magnetic
properties could help in these cases. A double-blind randomized clinical trial was designed to use
Magnetic Tape® versus placebo Kinesio tape. Blood flow variables were evaluated using pulsed
power Doppler ultrasound. Resistance index, pulsatility index, systolic velocity, and diastolic velocity
were measured. The pressure pain threshold was measured using algometry in 22 subjects. The results
reveal significant differences between the groups for the pulsation index variable (8.06 [5.16, 20.16] in
Magnetic Tape® versus 5.50 [4.56, 6.64] in Kinesio tape) and lower (0.98 [0.92, 1.02] for Magnetic Tape®
versus 0.99 [0.95, 1.01] for Kinesio tape) in the resistance index variable. The pressure pain threshold
variable presented significant differences at multiple levels. The application of Magnetic Tape® causes
immediate effects on blood flow and pain and could be a technique of choice for pain modulation.
Further studies would be necessary.
Keywords: Magnetic Tape; low-back pain; power pulsed Doppler; pressure pain threshold
1. Introduction
Chronic low-back pain (CLBP) is one of the main reasons for loss of function, resulting
in job absenteeism and decreased quality of life [1,2]. Chronic low-back pain (CLBP) is
defined as mechanical musculoskeletal pain in the lower back that has no known cause
and lasts for more than 12 weeks [3]. The probability of developing low-back pain is
high, with reported lifetime prevalence rates greater than 20% [4]. Research has shown
several conditions associated with CLBP [5], such as sex—it is common in women—obesity,
smoking, and aging. Commonly pain relief is one of the primary goals in the rehabilitation
of patients with low-back pain [6]. Conservative interventions managing low-back pain
typically include physical therapy and medication management [7]. Additionally, it has
been demonstrated that therapeutic exercise such as the McKenzie method, stabilization
exercises, and strength-building exercises [8] can be beneficial.
At the cellular level, endogenous ion fluctuations are important for the regulation
of cell activity. Biologically, bioelectrical signals provide pathways to restore normal
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functioning and homeostasis after injury [9]. It has been demonstrated that magnetic
fields positively influence human tissue and result in several therapeutic effects, such
as pain relief, bone regeneration, muscle regeneration, improved nerve functioning, and
improvement in tissue vascularization [10–18]. Additionally, animal studies have identified
increased vascularization in rabbits when exposed to static magnetic fields (SMFs) [16].
SMF therapy has been used for centuries to control pain, but the mechanism by which
it reduces pain is unclear. One theory proposes that nociceptive C fibers have a lower
threshold potential and that magnetic fields selectively attenuate neuronal depolarization
by changing the resting membrane potential [10,19]. A second theory suggests that mag-
netic fields promote increased blood flow through the skin, subcutaneous tissue, muscle
tissue, and ligament tissues [20]. A third theory suggests that SMFs affect the kinetics of
ion binding in cellular macromolecules directly, which modulates the release of cytokines
and other factors [21,22].
Since the 1990s, there has been an expansion in efforts to develop various medical
applications using SMF therapy and, specifically, magnetic nanoparticles (MNs). External
magnetic fields interact with magnetic nanoparticles and thus could have a direct effect
on tissues, cells, or biomolecules [23]. From the different MNs that have been developed,
those that present a rapid change of magnetic state with the application of an external
magnetic field are usually desired [12]. Due to their small dimensions, MNs do not exhibit
any magnetization unless in contact with an external magnetic field [23]. The clinical
application of magnetic nanomaterials is due to their biocompatibility, versatility, and
being minimally toxic and highly sensitive even to small external particles, creating a wide
range of uses [23].
Magnetic nanoparticles are attracting increased attention due to their potential to
improve conventional therapeutic procedures and clinical diagnostics, thus providing novel
biomedicine approaches [12]. Magnetic nanoparticles can be designed for the prevention,
diagnosis, and treatment of diseases [12]. The result of the review carried out by McKay
et al. [16] indicates that nearly half of the cited experiments (10 of 27 studies) reported a
vasodilatory effect due to magnetic fields (MFs). Magnetic nanoparticles are emerging as
an essential class of biomedical functional nanomaterials in areas such as hyperthermia.
Combining magnetic particles with polymeric biomaterials has shown great potential
for tissue repair, such as bone, muscle, nerve, and cardiac tissue regeneration [8]. The
application of magnetic hyperthermia (MH) makes this technique a promising tool for
cancer treatments and is currently one of the more intense areas of nanotechnology research
in the biomedical field [12].
Based on current evidence, it could be concluded that magnetotherapy could provide
a non-invasive, safe, and easy method to treat pain [24]. Furthermore, magnetotherapy
might offer the potential to reduce spending on medical care for the management of
chronic musculoskeletal disorders [25]. Kinesiology tape (KT) has been used to influence
vascularization and blood flow using various application methodologies. If KT is applied
with or without tension, it does not have local effects on resistance indices, blood flow,
circumference, and volume [26]. There has been no report of increased paraspinal blood
flow nor a decrease in the perceived pain in the spine [27].
Magnetic Tape® is an adhesive elastic tape that incorporates magnetic nanoparticles
without the ability to create magnetic fields until it comes into contact with electromagnetic
fields such as those generated by living beings (see Supplementary Material Video 1). The
primary aim of this study was to investigate the effect of Magnetic Tape® with magnetic
nanoparticles (MT) applied to the lumbosacral area in subjects with low-back pain on the
vascularization of the lower limbs. The secondary aim was to determine if the Magnetic
Tape® had an immediate effect on pain with posterior to anterior pressure applied to the
spinous processes of the spine.
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2. Materials and Methods
A randomized double-blinded clinical trial was designed. For this pilot study, a
convenience sample of patients with low-back pain was selected from the private practice
of the faculty of Physiotherapy of the University of Valencia (Spain). The ethics committee
from the University of Valencia approved this study (Nº 1551975), and it was registered on
clinicaltrials.gov (NCT04836468). The recommendations of the “Consolidated Standards of
Reporting Trials” (CONSORT) were followed [28] (Figure 1).
Figure 1. CONSORT flow diagram.
The subjects for this study were recruited based on the study inclusion and exclusion
criteria. The inclusion criteria consisted of: subjects with low-back pain, aged between 18
and 65 years, living in Valencia, diagnosed by a medical doctor, and able to read Spanish
so that informed consent could be given. The exclusion criteria were not having the age
requirement, having conditions that would be a contraindication for the adhesive tape such
as allergies, being pregnant, having a pacemaker, any contraindication of electromagnetic
fields, neurological diseases, or taking any medication that may interact with magnetic
fields. If the subjects met the study criteria, they provided written consent to participate in
this study. At that point, demographics and preintervention data were collected.
To measure blood flow in each lower extremity of the subjects, the Alpinion E-CUBE
12 ultrasound device (Alpinion Medical Systems Co., Ltd., Seoul, Korea) with an L3-12H
linear array was used (64 mm footprint). Doppler ultrasound software was installed. A
sonographer with more than ten years’ experience measured, with pulsed power Doppler
ultrasound, blood flow in the femoral artery of the subjects in the supine position. Systolic
speed (SM), diastolic speed (SD), the ratio between both (SD), pulsation index (PI), and
arterial resistance index (IR) were measured (Figure 2). Another researcher measured the
pressure pain threshold (PPT) using a Wagner Force Dial FDK 20 algometer with a 1cm2
footprint following the protocol published in previous studies [29]. The PPT was evaluated
with the subjects in the prone position.
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Figure 2. Pulsed Doppler exam.
After baseline blood flow and PPT measures were obtained, the subjects were ran-
domized using sealed envelopes and then were taped, by a third researcher, with either
the Magnetic Tape® (MT) or placebo (KT). During testing, the researchers and subjects
were blinded for the type of tape application, patient allocation, or patient identification.
The tape was applied transversely relative to the spinous processes of L4 and L5. There
was 0% elongation of the tape, thus not creating any tension both in the MT and KT tape
application. The MT and KT tapes were alike in appearance (Figure 3). Following the tape
application, the pulsed power Doppler ultrasound blood flow and PPT measures were
repeated.
Figure 3. Magnetic Tape® and Kinesio tape application. Tape application in lumbar region (a) and
tape preparation, only neodymium magnet allow identification (b).
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Statistical Analysis
For the statistical analysis, the R Ver. 3.5.1. (R Foundation for Statistical Computing,
Institute for Statistics and Mathematics, Welthandelsplatz 1, 1020 Vienna, Austria) was
used. The level of significance was established at p < 0.05. The distribution of quantitative
variables of each test was tested with the Shapiro–Wilk test. This analysis demonstrated
that the variables were not normally distributed for both groups. Quantitative variables
were described with median and interquartile range and qualitative variables with absolute
and relative frequencies. Due to the lack of normality of the data and the small sample
size [30], an exact permutation test was applied to the final values of the outcome variables
between groups. The effect size was defined with the non-parametric r statistic, as 0.1–0.4
(small), 0.4–0.6 (moderate), and >0.6 (large).
3. Results
A total of 22 subjects were sampled by randomization: 12 (n = 12) received the
Magnetic Tape® KT, and the remaining subjects received the placebo KT (n = 10). The
demographic distribution of the variables for blood flow in systolic pressure (SM), diastolic
pressure (SD), the ratio between both (SD), pulsation index (PI), and arterial resistance
index (IR) can be found in Table 1. There were no significant differences between baseline
groups.









Gender, n (%) Female 6 (50.0) 4 (40.0) 0.969




DF 3.07 [1.67, 4.47] 2.09 [0.47, 4.04] 0.448
SD 7.65 [4.85, 14.96] 8.96 [6.29, 21.93] 0.575
PI 5.11 [4.14, 6.11] 4.14 [3.85, 6.04] 0.644
IR 0.95 [0.87, 1.04] 0.95 [0.88, 0.99] 0.843
Data expressed with median [interquartile range] or with absolute and relative values (%). Systolic pressure
(SM), diastolic pressure (SD), ratio between both (SD), pulsation index (PI), and arterial resistance index (IR).
a Significant if p < 0.05.
Following the application of either tape, the subject’s pain perception was measured
utilizing the pressure pain threshold. A significant difference at multiple vertebrae levels
was found. The distribution of quantitative variables of each test was tested with the
Shapiro–Wilk test. This analysis demonstrated that the variables were not normally dis-
tributed in both groups. For this reason, non-parametric statistics were used to evaluate
the data.
A hypothesis test was performed to check whether the application of the Magnetic Tape®
represents a significant change in either the PPT and/or arterial flow (Tables 2 and 3).
3.1. Non-Parametrics Analysis: Mann–Whitney U Test
We applied the Mann–Whitney U test between groups with the post-treatment values
of all the variables, verifying that there were no significant differences (Table 3).
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Placebo Tape Group Difference (95%CI) p Value a r (95%CI)
SM 22.57 [20.21, 27.45] 25.86 [20.29, 32.41] −3.29 (−10.42, 3.77) 1 0.141 (0, 0.571)
DF 1.31 [0.45, 1.92] 0.77 [0.20, 2.16] 0.535 (−1.21, 1.31) 1 0.127 (0.018, 0.515)
SD 17.04 [11.56, 57.00] 53.83 [10.75, 104.25] −36.79 (−77.14, 11) 1 0.155 (0.007, 0.499)
PI 8.06 [5.16, 20.16] 5.50 [4.56, 6.64] 2.565 (−0.86, 14.7) <0.001 0.323 (0.023, 0.668)
IR 0.98 [0.92, 1.02] 0.99 [0.95, 1.01] −0.005 (−0.07, 0.1) <0.001 0.007 (0.011, 0.519)
Data expressed with median [interquartile range]. R: non-parametric effect size. 95%CI: 95% confidence interval. a significant if p < 0.05.
Systolic pressure (SM), diastolic pressure (SD), ratio between both (SD), pulsation index (PI), and arterial resistance index (IR).
Table 3. Mann-Whitney U test calculations.






Systolic pressure (SM), diastolic pressure (SD), ratio between both (SD), pulsation index (PI), and arterial resistance
index (IR). a Significant if p < 0.05.
3.2. Permutation Test
We applied a permutation test, both with the Monte Carlo simulation and exact, between
groups with the post-treatment values of all variables. With the Monte Carlo simulation,
significant differences were observed between groups in the PI variable, while with the exact
permutation test, the differences occurred in the PI and IR variables (Table 4).
Table 4. Permutation test.
Monte Carlo Simulation Exact Permutation
Variables p Value a Variables p Value a
SM 0.928 SM 1
DF 0.72 DF 1
SD 0.653 SD 1
PI 0.015 PI <0.001
IR 0.359 IR <0.001
Systolic pressure (SM), diastolic pressure (SD), ratio between both (SD), pulsation index (PI), and arterial resistance
index (IR). a Significant if p < 0.05.
3.3. Mann–Whitney U Test with the Pre-Treatment Difference
We applied the Mann–Whitney U test between groups with the pre-treatment differ-
ence of all variables. There are significant differences between the two groups in the PI
variable (Table 5).
Table 5. Mann–Whitney U test.






Systolic pressure (SM), diastolic pressure (SD), ratio between both (SD), pulsation index (PI), and arterial resistance
index (IR). a significant if p < 0.05.
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3.4. Permutation Test with Pre-Treatment Difference
We applied a permutation test, both with the Monte Carlo simulation and exact,
between groups with the pre-treatment difference of all variables. With the Monte Carlo
simulation, significant differences between groups are observed in the PI variable, while
with the exact permutation test, the differences occurred in the PI and IR variables.
3.5. Non-Parametric Ancova
A non-parametric ANCOVA was calculated for each variable using permutations,
with the post-treatment result as the dependent variable, the group as the variable of
interest, and the pre-treatment variable as the baseline covariate. Significant differences
between the two groups were found in the PI variable.
3.6. Boostrap Linear Mixed Model
A bootstrap mixed linear model with a random intercept was calculated for each
variable, with the post-treatment result as the dependent variable, the group as the variable
of interest, the pre-treatment variable as the baseline covariate (fixed effects), and the
subjects as random effects. Significant differences between the two groups were observed
in the IR variable (Table 6).
Table 6. Bootstrap mixed linear model.






Systolic pressure (SM), diastolic pressure (SD), ratio between both (SD), pulsation index (PI), and arterial resistance
index (IR). 95%CI: 95% confidence interval. a significant if it does not contain the zero value.
We evaluated the model with the significant PI variable with the backward stepwise
method, starting with fixed effects saturated with the pre-treatment Group–SM interaction
and ending with the random-effects model, only with the intercept. The ANOVA table
shows significant differences between the Group*SM versus Group+SM (p = 0.006) and
Group+SM versus Group (p < 0.001) models; however, the more complex model is non-
significant, and thus we chose the initial Group+SM model that adequately explains the
variability of the data and is significant in the group (Table 7).
Table 7. Evaluation of the model with the PI variable.
AIC BIC Log Likelihood-Ratio Test p Value a
Group*SM vs.
Group+SM 145.528 150.983 7.625 0.006
Group+SM vs. Group 202.227 206.592 58.699 <0.001
Group vs. Intercept 202.221 205.494 1.994 0.158
Systolic pressure (SM). a significant if p < 0.05.
The linear mixed model shows how the final values in the PI variable in the placebo
tape group are −4.255 ± 2.479 times lower than in the Magnetic Tape® group; this difference
is significant (regression coefficients (95%CI) = −9.694, −0.875) with a large and significant
effect size (R2 = 0.93, 95%CI (0.883, 0.966)) (Table 8).
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Table 8. Linear mixed model.
Coefficients Standard Error Degrees of Freedom t Value 95%CI Bootstrap Regression Coefficients a
Intercept −1.634 2.055 19 −0.795 −5.557, 3.062
Group (placebo) −4.255 2.479 19 −1.716 −9.694, −0.875
a significant if it does not contain the zero value.
3.7. Pain Analysis
We applied an exact permutation test between groups with all variables. The pain was
measured using the pressure pain threshold and showed significant differences at multiple
vertebrae levels (Table 9).
Table 9. Exact permutation test: pressure pain threshold.
Vertebral Level Magnetic Tape® Group Placebo Tape Group p Value a
L1 postreatment first time 6.3 ± 1.149 4.32 ± 0.955 <0.001
L1 postreatment second time 6.333 ± 1.15 4.3 ± 0.957 <0.001
L2 postreatment first time 6.35 ± 0.967 4.62 ± 0.55 <0.001
L2 postreatment second time 6.3 ± 0.844 4.62 ± 0.55 <0.001
L3 postreatment first time 6.583 ± 0.913 4.38 ± 0.726 <0.001
L3 postreatment second time 6.633 ± 0.956 4.38 ± 0.76 <0.001
L4 pretreatment first time 3.85 ± 0.602 3.68 ± 0.502 <0.001
L4 pretreatment second time 3.883 ± 0.688 3.68 ± 0.563 <0.001
L4 postreatment first time 6.567 ± 0.878 3.64 ± 0.483 <0.001
L4 postreatment second time 6.517 ± 0.868 3.62 ± 0.507 <0.001
L5 postreatment first time 6.133 ± 1.035 3.72 ± 0.676 <0.001
L5 postreatment second time 6.117 ± 1.042 3.68 ± 0.638 <0.001
S1 postreatment first time 6.75 ± 0.92 4.28 ± 0.642 <0.001
S1 postreatment second time 6.783 ± 0.972 4.32 ± 0.642 <0.001
S2 postreatment first time 6.767 ± 0.802 4.52 ± 0.228 <0.001
S2 postreatment second time 6.833 ± 0.812 4.56 ± 0.251 <0.001
S3 postreatment first time 6.8 ± 0.817 4.48 ± 0.295 <0.001
S3 postreatment second time 6.8 ± 0.883 4.54 ± 0.336 <0.001
S4 postreatment first time 6.8 ± 0.81 4.74 ± 0.288 <0.001
S4 postreatment second time 6.833 ± 0.821 4.72 ± 0.277 <0.001
a showed only significant differences set at p < 0.05.
Furthermore, there were significant differences between both groups in the PI (Z =
1.349, p < 0.001) and IR (Z = 0.54, p < 0.001) variables, with a small and significant effect
size. In both cases, the final values were higher in the Magnetic Tape® group (8.06 [5.16,
20.16] versus (5.50 [4.56, 6.64]) in the PI variable and lower (0.98 [0.92, 1.02]) versus (0.99
[0.95, 1.01]) in the IR variable. In the Magnetic Tape® group, there was an increase in the
values of the PI variable (from 5.11 [4.14, 6.11] to 8.06 [5.16, 20.16]) with a slight increase in
the IR variable (from 0.95 [0.87, 1.04] to 0.98 [0.92, 1.02]). In addition, in the placebo tape
group, there was a lower increase in the values of the PI variable (from 4.14 [3.85, 6.04] to
5.50 [4.56, 6.64]) with an increment similar to the Magnetic Tape® group in the IR variable
(from 0.95 [0.88, 0.99] to 0.99 [0.95, 1.01]) (Table 2).
4. Discussion
The primary aim of this study was to investigate whether the effect of a tape with
magnetic nanoparticles applied to the lumbosacral area in subjects with low-back pain
has a systemic effect on the vascularization of the lower limbs. The secondary aim was to
determine if the Magnetic Tape® had an immediate effect on pain with posterior to anterior
pressure applied to the spinous processes of the spine.
The results of this study reveal the modulation of blood flow, evaluated with pulsed
Doppler ultrasound at the femoral artery. The modifying variables of the arterial resis-
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tance index and the pulsatility index were three times more than in the placebo group.
Additionally, there was a decrease in the level of PPT at various vertebral levels.
Our research findings are in line with the results of previous studies of McKay
et al. [11]. Results of Monfrecola et al. [31] demonstrate improved cutaneous blood flow
by 62%. In the same review, a study with mice was incorporated where the speed of the
blood flow increased in a range of 15% to 45%. In our study, the application of SMFs
produced an increase in blood flow between 20% and 40%, which concurs with the findings
of Monfrecola et al. [31].
Schuhfried et al. [32] studied the effect of time-varying SMFs on microcirculation and
the alteration of temperature in human feet. Low-frequency fields were used, causing
an increase in blood velocity in a range of 20% to 45% after exposure. The pulsed power
Doppler measurements observed in very light exercise do improve the mean blood velocity
(MBV) of the femoral artery from 10 cm/sec to 20 cm/s [33]. Similar results were found
after a slight quadriceps contraction, causing a rapid increase in the MBV of the femoral
artery from 10.1 cm/s to 28.1 cm/s [34]. The findings of our study are comparable to
these results, which indicates that the application of Magnetic Tape® could help improve
vascularization. Any variation in the diameter of the small vessels will more easily affect
the diastolic velocity. In contrast, variations in the large vessels reflect a more significant
variation in systolic velocities with increased blood flow velocity [35]. The sympathetic
nervous system stimulation induced by the Magnetic Tape® could be responsible for the
observed blood flow changes.
Gossling HR et al. [13] demonstrated in 1992 that the activation of body magnetic
fields in different traumatic pathologies could be as effective as surgical interventions.
Li Y et al. [14] reached the same conclusions in 2020. Both Gossling et al. and Li et al.
concluded that the treatment of non-healing bone fractures with electromagnetic fields
has proven more successful than the traditional approach. Given the costs and potential
dangers of surgery, magnetic field therapy should be considered an effective alternative.
Additionally, for healing to occur, it is necessary to improve vascularization. Our study
also demonstrated that NMs reduce pain.
Current trends in biology and medicine research using MNs are evaluating the effects
on tissues, cells, and biomolecules [12]. MNs can be designed for the prevention, diagnosis,
and treatment of disease [12]. Magnetic compounds activated through external magnetic
fields have been shown to further enhance the biological properties of cells [11]. They can
stimulate endothelial cell proliferation, promoting osteogenesis for bone repair in vivo [11].
One of the most intense areas of nanotechnology research in the biomedical field is hyper-
thermia due to increased vascularization [12]. The nanoparticles used in this study were
activated by external magnetic fields of the body [23]. Our study implies that the Magnetic
Tape® nanoparticles created a rapid change in the epidermis’s magnetic state affecting the
local blood flow.
The effect of the Magnetic Tape® on pain is comparable with Brown et al. [10] in
which chronic low-back pain improved by 40% after using 500 Gauss active magnets on
trigger points, while the use of placebo magnets produced a 3% worsening of symptoms.
The magnetic field acts as the vehicle to induce ion flow and does not stimulate the
nerve tissue itself [36]. However, once the ion flow is created in the epidermal cells, the
mechanism of electrical and magnetic stimulation at the neural level is the same, producing
the depolarization of the axon and the initiation of the action potential [36]. Additionally,
epidermal cells, especially the Langerhans cells, on which ion flow is induced, act on the
lymphatic system and are innervated by the sympathetic autonomic nervous system [37]. A
recent publication by Chao et al. 2021 [38] related epidermal dysfunctions to modifications
in the thalamus; this implies a centralized effect. We also postulate that it is a priority due
to its ectodermal embryological origin.
We agree with Brown et al. [10] that the skin is a part of the mechanism by which
SMFs act on our body in a systematic way. The hypothesis of the mechanism of action of
Magnetic Tape® is that it acts superficially on epidermal cells. Our results demonstrate
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physiological baseline state changes. Future research is needed to explore the possible
benefits for other conditions and locations using Magnetic Tape®.
Finally, we would like to mention that clinicians have used Kinesiology tape or Kinesio
to influence vascularization and blood flow in the area of the tape application [25–27].
However, the effects of kinesiology tape (KT) on vascular flow and pain have not been
demonstrated. This concurs with previous systematic reviews [39,40], revealing no relation
between KT and pain relief.
5. Limitations
To our knowledge, no previous studies evaluated the effects of magnetic nanoparticles
in a tape on an epidermis. Our study only evaluated the immediate effects of the Magnetic
Tape® on pain and vascularization. Therefore, no middle and long-term effect can be
inferred. Future research is needed to evaluate long-term effects and further explore the
effects of the Magnetic Tape® on microcirculation. Additionally, the effects of Magnetic
Tape® on the autonomic nervous system should be explored.
6. Conclusions
The application of Magnetic Tape® in subjects with low-back pain resulted in im-
mediate and significant pain reduction. There was an immediate increase in blood flow
parameters after the application of Magnetic Tape®. The reduction of pain and the im-
provement of the analyzed blood flow parameters indicate that Magnetic Tape® could be
used to manage pain. Magnetic Tape® provides a non-invasive, safe, and simple method
to manage perceived pain. Further studies are needed to explore further how magnetic
nanoparticles affect pain perception.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/s21196517/s1, Video S1: Magnetic Tape test.
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